Carl Zeiss Meditec has invested in MicroOptx Inc., becoming a shareholder in the Minneapolis-based company, according to a press release.MicroOptx focuses on minimally invasive glaucoma surgery devices to reduce intraocular pressure, the release said.“…
Author: Healio ophthalmology
VIDEO: Updates on new steroid delivery platforms
KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting here, Eric D. Donnenfeld, MD, discusses new systems for delivery of steroids for treatment of pain and inflammation after ophthalmic surgery.
VIDEO: New drug delivery platforms for glaucoma
KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting here, Nathan M. Radcliffe, MD, presents an overview of the latest advances in sustained glaucoma drug delivery platforms.
New online video library compiles old and new surgical videos
Lucio Buratto , MD, presents “okyo.eu,” an open-access online video library collection of ophthalmic videos that is dynamically open to further contributions, selected by a scientific committee.“The project took shape from an idea of my son Julien when…
Two compounding pharmacies voluntarily recall sterile products
Sterile products, including ophthalmics, have been voluntarily recalled by two compounding pharmacy operations.In response to FDA concerns regarding environmental controls, potential cross-contamination and lack of product specific process validations,…
VIDEO: Device and technique updates in MIGS
KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting here, Thomas W. Samuelson, MD, discusses the latest advancements in MIGS, reviewing the procedures through stage of disease and degree of disruption.
FDA approves Dextenza for treatment of ocular inflammation
Dextenza, the first FDA-approved intracanalicular insert for the treatment of postoperative ocular pain, is now also approved for the treatment of ocular inflammation after ophthalmic surgery, Ocular Therapeutix announced in a press release.The FDA app…
New technique for soft cataracts tops OSN’s news from ASCRS
The American Association of Cataract and Refractive Surgery held its annual meeting May 3-7 in San Diego.Here are the top five articles from Healio.com/OSN’s coverage of the meeting: Non-fragmentation phaco technique removes soft cataractsThe new RAPID…
Alimera’s Iluvien receives positive funding recommendation
The U.K.’s National Institute of Health and Care Excellence has recommended funding for Iluvien as treatment for noninfectious posterior uveitis, Alimera announced.With this recommendation, the U.K.’s National Health Service will pay for prescriptions …
VIDEO: First US patient implanted with artificial iris has good visual, anatomic results
KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting here, Karolinne Rocha, MD, discusses pearls for implanting the CustomFlex artificial iris (HumanOptics/Clinical Research Consultants) and the visual and anatomic results from the first patient implanted i…
Glaukos to acquire Dose Medical, move into retinal space
Glaukos Corporation has entered into a definitive Agreement and Plan of Merge to acquire Dose Medical Corporation, a developer of microinvasive, bioerodible, sustained-release drug delivery platforms for various retinal diseases.The acquisition will co…
NovaBay appoints new CEO, CFO
NovaBay Pharmaceuticals has named Justin Hall as its new president and CEO and Jason Raleigh as its new chief financial officer, according to a press release.The two have served in interim CEO and CFO roles since March.”Justin and Jason have proven the…
Visual acuity results ‘excellent’ with extended range of vision IOLs
Binocularly implanted extended range of vision IOLs provide “excellent” stereoacuity at distance and near and a high quality of vision, according to a study.Fifty patients were bilaterally implanted with the Tecnis Symfony IOL (Johnson & Johnson Vision…
VIDEO: Cataract surgeons focus on dry eye, reduced drops, new IOLs
KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting here, John A. Hovanesian, MD, addresses the latest in cataract surgery, including the management of dry eye, reducing eye drop burden and new technologies in IOLs.
Central serous chorioretinopathy patient treated with Lutronic’s R:GEN laser in Korea
Lutronic Vision’s R:GEN retina treatment laser has been used to treat the first patient with central serous chorioretinopathy at Seoul National University Hospital, the company announced in a press release.R:GEN received conditional new health technolo…
LipiFlow more effective than warm compress for dry eye disease
One session of vectored thermal pulsation was more efficacious than a warm compress for treating dry eye disease, according to a study.The systematic review and meta-analysis consisted of 385 patients from four randomized controlled trials that compare…
VIDEO: The next 5 to 10 years in presbyopia correction
KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting here, Elizabeth Yeu, MD, envisions that refractive surgeons will have more than 30 surgical solutions for presbyopia in the next 5 to 10 years.
Retinitis pigmentosa stem cell study tops ARVO news
The annual Association for Research in Vision and Ophthalmology meeting was held in Vancouver, British Columbia, from April 28 to May 2.Here are the top five stories and videos from Healio.com/OSN’s coverage of the meeting: Phase 2a study shows improve…
Ribomic’s wet AMD candidate shows positive phase 1/2a topline results
A single dose of RBM-007, an oligonucleotide-based aptamer with anti-FGF2 activity, showed positive topline results in a phase 1/2a clinical trial in wet age-related macular degeneration patients, according to a press release.RBM-007 (Ribomic) was well…
Antihistamine-releasing contact lens relieves symptoms of ocular allergy
In two parallel clinical trials, an antihistamine-releasing contact lens reduced symptoms in patients with allergic conjunctivitis.Two hundred forty-four subjects were randomly assigned to be fitted with ketotifen-containing lenses in one or both eyes …